CN112972431A - 一种选择性释放优性对映异构体的透皮制剂渗透膜的制备及应用 - Google Patents
一种选择性释放优性对映异构体的透皮制剂渗透膜的制备及应用 Download PDFInfo
- Publication number
- CN112972431A CN112972431A CN202110116443.7A CN202110116443A CN112972431A CN 112972431 A CN112972431 A CN 112972431A CN 202110116443 A CN202110116443 A CN 202110116443A CN 112972431 A CN112972431 A CN 112972431A
- Authority
- CN
- China
- Prior art keywords
- amlodipine
- membrane
- permeable membrane
- enantiomer
- transdermal preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 78
- 238000002360 preparation method Methods 0.000 title claims abstract description 36
- 239000003814 drug Substances 0.000 claims abstract description 23
- 229940079593 drug Drugs 0.000 claims abstract description 20
- HTIQEAQVCYTUBX-KRWDZBQOSA-N (S)-amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@@H]1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-KRWDZBQOSA-N 0.000 claims description 33
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 32
- 229950008554 levamlodipine Drugs 0.000 claims description 31
- HTIQEAQVCYTUBX-UHFFFAOYSA-N amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)C1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-UHFFFAOYSA-N 0.000 claims description 19
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 18
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 229920002845 Poly(methacrylic acid) Polymers 0.000 claims description 17
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 14
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 14
- 230000001186 cumulative effect Effects 0.000 claims description 13
- HTIQEAQVCYTUBX-QGZVFWFLSA-N (R)-amlodipine Chemical compound CCOC(=O)C1=C(COCCN)NC(C)=C(C(=O)OC)[C@H]1C1=CC=CC=C1Cl HTIQEAQVCYTUBX-QGZVFWFLSA-N 0.000 claims description 12
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 12
- 229960000528 amlodipine Drugs 0.000 claims description 11
- 239000003054 catalyst Substances 0.000 claims description 10
- 238000006243 chemical reaction Methods 0.000 claims description 10
- 239000003431 cross linking reagent Substances 0.000 claims description 8
- 239000003999 initiator Substances 0.000 claims description 8
- 239000000178 monomer Substances 0.000 claims description 8
- -1 cerous sulfate amine Chemical class 0.000 claims description 7
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 238000010438 heat treatment Methods 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 6
- ZIUHHBKFKCYYJD-UHFFFAOYSA-N n,n'-methylenebisacrylamide Chemical compound C=CC(=O)NCNC(=O)C=C ZIUHHBKFKCYYJD-UHFFFAOYSA-N 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 238000002791 soaking Methods 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N sulfuric acid Substances OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 claims description 6
- 229910000333 cerium(III) sulfate Inorganic materials 0.000 claims description 4
- 239000003480 eluent Substances 0.000 claims description 4
- 239000012466 permeate Substances 0.000 claims description 4
- 230000035484 reaction time Effects 0.000 claims description 2
- 230000008961 swelling Effects 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 3
- 238000004140 cleaning Methods 0.000 description 4
- 230000002860 competitive effect Effects 0.000 description 4
- 238000009792 diffusion process Methods 0.000 description 4
- 239000012153 distilled water Substances 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000001179 sorption measurement Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000011914 asymmetric synthesis Methods 0.000 description 3
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 description 2
- MWUXSHHQAYIFBG-UHFFFAOYSA-N Nitric oxide Chemical compound O=[N] MWUXSHHQAYIFBG-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 241001439211 Almeida Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229940127291 Calcium channel antagonist Drugs 0.000 description 1
- 108091006146 Channels Proteins 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 206010047139 Vasoconstriction Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- PGJHGXFYDZHMAV-UHFFFAOYSA-K azanium;cerium(3+);disulfate Chemical compound [NH4+].[Ce+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O PGJHGXFYDZHMAV-UHFFFAOYSA-K 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000000480 calcium channel blocker Substances 0.000 description 1
- 238000005251 capillar electrophoresis Methods 0.000 description 1
- 238000002045 capillary electrochromatography Methods 0.000 description 1
- 238000007036 catalytic synthesis reaction Methods 0.000 description 1
- 239000012069 chiral reagent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000012377 drug delivery Methods 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 230000025033 vasoconstriction Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7007—Drug-containing films, membranes or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4422—1,4-Dihydropyridines, e.g. nifedipine, nicardipine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/04—Acids; Metal salts or ammonium salts thereof
- C08F220/06—Acrylic acid; Methacrylic acid; Metal salts or ammonium salts thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- General Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polymers & Plastics (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110116443.7A CN112972431B (zh) | 2021-01-28 | 2021-01-28 | 一种选择性释放优性对映异构体的透皮制剂渗透膜的制备及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110116443.7A CN112972431B (zh) | 2021-01-28 | 2021-01-28 | 一种选择性释放优性对映异构体的透皮制剂渗透膜的制备及应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112972431A true CN112972431A (zh) | 2021-06-18 |
CN112972431B CN112972431B (zh) | 2022-10-28 |
Family
ID=76345707
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110116443.7A Active CN112972431B (zh) | 2021-01-28 | 2021-01-28 | 一种选择性释放优性对映异构体的透皮制剂渗透膜的制备及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112972431B (zh) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113332964A (zh) * | 2021-07-02 | 2021-09-03 | 肇庆医学高等专科学校 | 磁性接枝微粒Fe3O4@SiO2-PAM的制备方法及其在氨氯地平吸附分离中的应用 |
CN113402684A (zh) * | 2021-07-02 | 2021-09-17 | 肇庆医学高等专科学校 | 一种磁性表面印迹材料的制备方法及其在识别与拆分氨氯地平中的应用 |
Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020198349A1 (en) * | 2001-03-02 | 2002-12-26 | Tucker Norton | Droplet polymerization method for synthesis of molecularly imprinted polymers |
CN1788832A (zh) * | 2004-12-17 | 2006-06-21 | 李连超 | 智能分子印迹手性拆分亲和膜及其制备方法 |
US20090281272A1 (en) * | 2005-12-07 | 2009-11-12 | Mip Technologies Ab | Monodisperse Molecularly Imprinted Polymer Beads |
KR20120093473A (ko) * | 2011-02-15 | 2012-08-23 | 충남대학교산학협력단 | 약물전달용 경피 흡수제제 |
CN102764598A (zh) * | 2012-07-17 | 2012-11-07 | 西安建筑科技大学 | 一种分离色氨酸异构体的分子印迹复合膜的制备方法 |
CN103833915A (zh) * | 2012-11-20 | 2014-06-04 | 南开大学 | 适于纯生物样品的分子印迹聚合物纳米颗粒及其制备方法 |
CN104725661A (zh) * | 2015-02-27 | 2015-06-24 | 湘潭大学 | 一种手性分离苯磺酸氨氯地平分子印迹膜的制备方法 |
CN104906093A (zh) * | 2015-05-18 | 2015-09-16 | 天津医科大学 | 漂浮缓释型胃内滞留液晶分子印迹药物载体及其制备 |
CN105294918A (zh) * | 2015-11-18 | 2016-02-03 | 陕西高新能源发展有限公司 | 一种苯磺酸氨氯地平印迹聚合物(mips)制备方法 |
CN107501591A (zh) * | 2016-06-14 | 2017-12-22 | 中国石油化工股份有限公司 | 一种双酚a分子印迹聚合物膜的制备与应用 |
CN108484816A (zh) * | 2018-03-19 | 2018-09-04 | 河北农业大学 | 一种吩噻嗪类药物族特异性的分子印迹聚合物和化学发光试剂盒及检测方法 |
WO2018160132A1 (en) * | 2017-02-28 | 2018-09-07 | National University Of Singapore | A method of making a molecularly imprinted polymer sensor |
-
2021
- 2021-01-28 CN CN202110116443.7A patent/CN112972431B/zh active Active
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20020198349A1 (en) * | 2001-03-02 | 2002-12-26 | Tucker Norton | Droplet polymerization method for synthesis of molecularly imprinted polymers |
CN1788832A (zh) * | 2004-12-17 | 2006-06-21 | 李连超 | 智能分子印迹手性拆分亲和膜及其制备方法 |
US20090281272A1 (en) * | 2005-12-07 | 2009-11-12 | Mip Technologies Ab | Monodisperse Molecularly Imprinted Polymer Beads |
KR20120093473A (ko) * | 2011-02-15 | 2012-08-23 | 충남대학교산학협력단 | 약물전달용 경피 흡수제제 |
CN102764598A (zh) * | 2012-07-17 | 2012-11-07 | 西安建筑科技大学 | 一种分离色氨酸异构体的分子印迹复合膜的制备方法 |
CN103833915A (zh) * | 2012-11-20 | 2014-06-04 | 南开大学 | 适于纯生物样品的分子印迹聚合物纳米颗粒及其制备方法 |
CN104725661A (zh) * | 2015-02-27 | 2015-06-24 | 湘潭大学 | 一种手性分离苯磺酸氨氯地平分子印迹膜的制备方法 |
CN104906093A (zh) * | 2015-05-18 | 2015-09-16 | 天津医科大学 | 漂浮缓释型胃内滞留液晶分子印迹药物载体及其制备 |
CN105294918A (zh) * | 2015-11-18 | 2016-02-03 | 陕西高新能源发展有限公司 | 一种苯磺酸氨氯地平印迹聚合物(mips)制备方法 |
CN107501591A (zh) * | 2016-06-14 | 2017-12-22 | 中国石油化工股份有限公司 | 一种双酚a分子印迹聚合物膜的制备与应用 |
WO2018160132A1 (en) * | 2017-02-28 | 2018-09-07 | National University Of Singapore | A method of making a molecularly imprinted polymer sensor |
CN108484816A (zh) * | 2018-03-19 | 2018-09-04 | 河北农业大学 | 一种吩噻嗪类药物族特异性的分子印迹聚合物和化学发光试剂盒及检测方法 |
Non-Patent Citations (4)
Title |
---|
KAIXIA LUO等: "Solid-Phase Extraction of S-(-)-Amlodipine from Plasma", 《JOURNAL OF APPLIED POLYMER SCIENCE》 * |
SHENZHI LAI等: "Rapid and efficient enantioseparation", 《JOURNAL OF SEPARATION SCIENCE》 * |
司汴京: "新一代分子印迹技术", 《化学进展》 * |
赖申枝: "表面印迹材料的制备及用于按氨氯地平药物的手性分离研究", 《万方》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113332964A (zh) * | 2021-07-02 | 2021-09-03 | 肇庆医学高等专科学校 | 磁性接枝微粒Fe3O4@SiO2-PAM的制备方法及其在氨氯地平吸附分离中的应用 |
CN113402684A (zh) * | 2021-07-02 | 2021-09-17 | 肇庆医学高等专科学校 | 一种磁性表面印迹材料的制备方法及其在识别与拆分氨氯地平中的应用 |
CN113402684B (zh) * | 2021-07-02 | 2022-02-18 | 肇庆医学高等专科学校 | 一种磁性表面印迹材料的制备方法及其在识别与拆分氨氯地平中的应用 |
CN113332964B (zh) * | 2021-07-02 | 2022-07-26 | 肇庆医学高等专科学校 | 磁性接枝微粒Fe3O4@SiO2-PAM的制备方法及其在氨氯地平吸附分离中的应用 |
Also Published As
Publication number | Publication date |
---|---|
CN112972431B (zh) | 2022-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112972431B (zh) | 一种选择性释放优性对映异构体的透皮制剂渗透膜的制备及应用 | |
Ali et al. | Polysaccharides chiral stationary phases in liquid chromatography | |
Xie et al. | Membranes and membrane processes for chiral resolution | |
Kawai et al. | Protein binding to polymer brush, based on ion-exchange, hydrophobic, and affinity interactions | |
US11918957B2 (en) | Affinity membrane and method of preparation | |
CN101402568A (zh) | 反应精馏与渗透汽化耦合生产乙酸乙酯的方法 | |
EP0532664B1 (en) | Supported chiral liquid membrane for the separation of enantiomers | |
Pu et al. | Progress of molecular imprinting technique for enantioseparation of chiral drugs in recent ten years | |
Higuchi et al. | Optical resolution of amino acid by ultrafiltration using recognition sites of DNA | |
Men et al. | Surface molecular imprinted membranes as a “gate” for selective transdermal release of chiral drug amlodipine | |
Ding et al. | New approach for chiral separation: from polysaccharide-based materials to chirality-responsive polymers | |
Liu et al. | Selective hydrogenation of propadiene and propyne in propene with catalytic polymeric hollow-fiber reactor | |
Sunsandee et al. | Thermodynamic parameters and isotherm application on enantiomeric separation of levofloxacin using hollow fiber supported liquid membrane system | |
Kasal et al. | Chiral Nafion membranes prepared by strong electrostatic binding of multiply positively charged β-cyclodextrin derivatives for tryptophan racemic mixtures’ separation | |
Suedee et al. | Direct resolution of propranolol and bupranolol by thin‐layer chromatography using cellulose derivatives as stationary phase | |
CN110575824B (zh) | 一种杂化多孔整体材料及其制备和应用 | |
CN109554826B (zh) | 一种对氨基酸具有高效选择性的纳米电纺膜及其制备方法 | |
Hadjmohammadi et al. | Chiral separation of methadone using solid membrane extraction based on chiral selector, solid membrane: sheep skin leather | |
CN112934200B (zh) | 一种超分子印迹固相微萃取纤维涂层及制备方法与应用 | |
Bonato et al. | Enantioselective HPLC analysis of propafenone and of its main metabolites using polysaccharide and protein‐based chiral stationary phases | |
CN112979511B (zh) | 一种用hplc分析及制备叔丁基亚磺酰胺对映异构体的方法 | |
CN112427023A (zh) | 一种三维大孔硼亲和印迹水凝胶吸附剂及其制备方法和应用 | |
Wang et al. | Chiral separation of trans-stilbene oxide through cellulose acetate butyrate membrane | |
CN112574062B (zh) | 卡比多巴对映异构体的分离制备方法 | |
CN109021173A (zh) | 一种胸腺五肽分子印迹核壳微球的制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240325 Address after: Room 207, 2nd Floor, Block B, Zone B, Cyberport, No. 402 South Middle Ring Street, Xuefu Industrial Park, Shanxi Transformation and Comprehensive Reform Demonstration Zone, Taiyuan City, Shanxi Province, 030006 Patentee after: Shanxi Tianshilan Technology Co.,Ltd. Country or region after: China Address before: 030051, Xueyuan Road, Shanxi Province, Taiyuan Province, No. 3 Patentee before: NORTH University OF CHINA Country or region before: China |